Abstract
Wastewater-based surveillance is a cost-effective concept for monitoring COVID-19 pandemics at a population level. Here, SARS-CoV-2 RNA was monitored from a total of 693 wastewater (WW) influent samples from 28 wastewater treatment plants (WWTP, N = 21–42 samples per WWTP) in Finland from August 2020 to May 2021, covering WW of ca. 3.3 million inhabitants (∼ 60% of the Finnish population). The relative quantity of SARS-CoV-2 RNA fragments in the 24h-composite samples was determined by using the ultrafiltration method followed by nucleic acid extraction and RT-qPCR assay targeted with N2-assay. SARS-CoV-2 RNA signals at each WWTP were compared over time to the numbers of new and confirmed COVID-19 cases in the sewer network area.
Over the 10-month surveillance period, the detection rate of SARS-CoV-2 RNA in WW was 79% (including 6% uncertain results), while only 24% of all samples exhibited gene copy (GC) numbers above the quantification limit. The range of the SARS-CoV-2 detection rate in WW varied from 33% (including 10% uncertain results) in Pietarsaari to 100% in Espoo. Only six out of 693 WW samples were positive with SARS-COV-2 RNA when the reported COVID-19 case number from the preceding 14 days was zero. Overall, the 14-day COVID-19 incidence was 7, 18 and 36 cases within the sewer network area when the probability to detect SARS-CoV-2 RNA in wastewater samples was 50%, 75% and 95%, respectively. The quantification of SARS-CoV-2 GC required significantly more COVID-19 cases: the quantification rate was 50%, 75% and 95% when the 14-day incidence was 110, 152 and 223 COVID-19 cases, respectively, per 100 000 persons. Multiple linear regression confirmed the relationship between the COVID-19 incidence and the SARS-CoV-2 GC quantified in WW at 15 out of 28 WWTPs (overall R2 = 0.36, p < 0.001). At four of the 13 WWTPs where a significant relationship was not found, the GC of SARS-CoV-2 RNA remained below the quantification limit during the whole study period. In the five other WWTPs, the sewer coverage was less than 80% of the total population in the area and thus the COVID-19 cases may have been inhabitants from the areas not covered.
Based on the results obtained, WW-based surveillance of SARS-CoV-2 could be used as an indicator for local and national COVID-19 incidence trends. Importantly, the determination of SARS-CoV-2 RNA fragments from WW is a powerful and non-invasive public health surveillance measure, independent of possible changes in the clinical testing strategies or in the willingness of individuals to be tested for COVID-19.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Finnish Government supplementary budget for COVID-19 research; the Ministry of Agriculture and Forestry [grant number 4400T-0807]; and the Academy of Finland [grant number 339415].
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Finnish Institute for Health and Welfare
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
ananda.tiwari{at}thl.fi (AT), anssi.lipponen{at}thl.fi (AL), anna-maria.hokajarvi{at}thl.fi (AH), anniina.sarekoski{at}thl.fi (AS), annastiina.rytkonen{at}thl.fi (AR), ilkka.miettinen{at}thl.fi (IM), tarja.pitkanen{at}thl.fi (TP)
ananda.tiwari{at}thl.fi (AT), anssi.lipponen{at}thl.fi (AL), anna-maria.hokajarvi{at}thl.fi (AH), anniina.sarekoski{at}thl.fi (AS), annastiina.rytkonen{at}thl.fi (AR), ilkka.miettinen{at}thl.fi (IM), tarja.pitkanen{at}thl.fi (TP)
ananda.tiwari{at}helsinki.fi, annastiina.rytkonen{at}helsinki.fi, tarja.m.pitkanen{at}helsinki.fi.
oskari.luomala{at}thl.fi (OL, AJ)
carita.savolainen-kopra{at}thl.fi (PO, HA, CSK)
Data Availability
This work is part of that carried out by the national COVID-19 task force at the Finnish Institute for Health and Welfare (THL). The wastewater-based surveillance results of SARS-CoV-2 in comparison to detected COVID-19 cases in the sewer network areas and the wastewater data is publicly available [In Finnish]. Further, the numbers of confirmed new COVID-19 cases reported in each municipality of Finland are publicly available.
https://www.thl.fi/episeuranta/jatevesi/jatevesiseuranta_viikkoraportti.html
